About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Nuclear Medicine Market

U.S. Nuclear Medicine Market Is Set To Reach 3.58 USD Billion By 2033, Growing At A CAGR Of 21.2

U.S. Nuclear Medicine Market by Type (Diagnostic Radiopharmaceuticals {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, Others], SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, Others]}, Therapeutic Radiopharmaceuticals), by Application (Neurology, Cardiology, Oncology, Others), by End-user (Hospitals & Clinics, Diagnostic Centers, Others), by Forecast 2026-2034

Oct 21 2025

Base Year: 2025

120 Pages

U.S. Nuclear Medicine Market Is Set To Reach 3.58 USD Billion By 2033, Growing At A CAGR Of 21.2

Key Insights

The U.S. Nuclear Medicine Market size was valued at USD 3.58 USD Billion in 2023 and is projected to reach USD 13.75 USD Billion by 2032, exhibiting a CAGR of 21.2 % during the forecast period. Nuclear Medicine is the branch of medicine that uses small amounts of radioactive substances or radiotracers to diagnose or treat various diseases; techniques include Positron emission tomography (PET), Single photon emission computed tomography (SPECT), and radionuclide therapy. Some of the attractive features are high-resolution imaging, early diagnosis, and personalized therapy. Specialization covers oncology, cardiology, and neurology, it improves the assessment of organ function and cellular processes. Current trends in the US market include improvement in molecular radiopharmaceuticals, epidemiological changes, and applications of hybrid imaging. Also, advancements in technologies and increased spending on healthcare facilities make the sector more developed and with better diagnoses.

U.S. Nuclear Medicine Trends

Rising demand for personalized medicine in diagnostic and therapeutic applications
Growing adoption of hybrid imaging technologies for accurate disease diagnosis
Increasing focus on theranostics for targeted cancer treatment

U.S. Nuclear Medicine Market Market Size and Forecast (2024-2030) — U.S. Nuclear Medicine Market Company Market Share

Driving Forces: What's Propelling the U.S. Nuclear Medicine Market

Rising Disease Burden: The escalating prevalence of chronic and life-threatening conditions such as cancer, cardiovascular diseases, neurological disorders (like Alzheimer's and Parkinson's), and inflammatory diseases is a primary driver. Nuclear medicine plays a crucial role in the early diagnosis, staging, treatment planning, and monitoring of these diseases, leading to an increased demand for its diagnostic and therapeutic applications.
Focus on Precision Medicine and Early Detection: There is a significant and growing emphasis on early, accurate, and personalized disease detection and intervention. Nuclear medicine techniques, with their ability to visualize biological processes at a molecular level, are instrumental in identifying diseases in their nascent stages, stratifying patient risk, and guiding targeted treatment strategies, thus enhancing patient outcomes.
Innovation in Radiopharmaceuticals: Continuous advancements in radiopharmaceutical development are revolutionizing the field. The introduction of novel, highly specific, and effective radiotracers allows for more precise imaging, better differentiation between benign and malignant tissues, and improved therapeutic efficacy. This ongoing innovation expands the diagnostic and therapeutic capabilities of nuclear medicine.
Increased Healthcare Investment and Technological Adoption: Growing healthcare expenditures, coupled with a societal demand for advanced and accurate diagnostic tools, are fueling investment in sophisticated medical imaging modalities, including nuclear medicine. The integration of AI and advanced imaging processing further enhances the value proposition and adoption of these technologies.
Supportive Government Policies and Research Initiatives: Proactive government initiatives, funding for research and development in nuclear medicine, and policies aimed at expanding access to these advanced technologies are fostering innovation, driving market growth, and increasing the availability of nuclear medicine services across the U.S.

Challenges and Restraints in the U.S. Nuclear Medicine Market

Limited reimbursement for nuclear medicine procedures
Concerns associated with radiation exposure
Stringent regulatory requirements for radiopharmaceutical production and use
Availability of alternative imaging modalities, such as MRI and CT

Emerging Trends in U.S. Nuclear Medicine

Development of novel radiopharmaceuticals for targeted therapies
Integration of Artificial intelligence and Machine learning in nuclear Medicine Imaging
Growing focus on personalized medicine and companion diagnostics

Growth Catalysts in the U.S. Nuclear Medicine Industry

Government initiatives to promote nuclear medicine research and development
Increasing investment in nuclear medicine infrastructure
Collaboration between pharmaceutical companies and research institutions

Market Segmentation: U.S. Nuclear Medicine Analysis

Type:

Diagnostic Radiopharmaceuticals
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals
Therapeutic Radiopharmaceuticals

Application:

Neurology
Cardiology
Oncology
Others

End-user:

Hospitals & Clinics
Diagnostic Centers
Others

Leading Players in the U.S. Nuclear Medicine Market

Lantheus (U.S.)
Cardinal Health (U.S.)
Bracco (U.S.)
GE Healthcare (General Electric Company) (U.S.)
CURIUM (France)
Bayer AG (Germany)
RLS, Inc. (U.S.)

Significant Developments in the U.S. Nuclear Medicine Sector

June 2023: SpectronRx and RLS (USA), Inc. announced an agreement to enhance the supply of radiopharmaceuticals.
May 2023: TG Imaging Solutions acquired Digirad Health, providing mobile nuclear medicine camera services.
September 2021: Gurnick Academy launched a nuclear medicine technologist program in California.

Comprehensive Coverage U.S. Nuclear Medicine Market Report

In-depth Market Dynamics Analysis: A thorough examination of key macroeconomic factors, evolving healthcare infrastructure, demographic shifts, and prevailing healthcare industry trends that significantly influence the U.S. nuclear medicine landscape.
Detailed Market Segmentation: Granular segmentation of the market by product type (including diagnostic agents like PET and SPECT tracers, and therapeutic radiopharmaceuticals), by application area (such as oncology, cardiology, neurology, endocrinology, and infectiology), and by end-user segment (hospitals, diagnostic imaging centers, academic and research institutions, and specialty clinics).
Key Player Profiling and Competitive Intelligence: Comprehensive profiles of leading companies operating in the U.S. nuclear medicine market, featuring detailed market share analysis, insights into recent strategic developments (partnerships, mergers, acquisitions), R&D pipelines, and an evaluation of their competitive strategies.
Emerging Technologies and Future Trends: An in-depth exploration of cutting-edge technologies poised to shape the future of nuclear medicine, including advancements in molecular imaging techniques, the growing role of theranostics (combining diagnostic and therapeutic capabilities), the development of novel radiometals, and the integration of artificial intelligence in image analysis and interpretation.
Regulatory and Reimbursement Landscape Assessment: A critical analysis of the current and evolving regulatory frameworks (FDA approvals, etc.) and reimbursement policies (Medicare, private insurance) that directly impact market access, adoption rates, and the financial viability of nuclear medicine procedures and products.
Identification of Challenges and Opportunities: A strategic assessment of the key hurdles hindering market growth (e.g., cost of technology, skilled workforce availability, regulatory complexities) alongside a detailed exploration of untapped opportunities for expansion and innovation within the U.S. market.
Future Market Projections: Robust and detailed forecasts of the U.S. nuclear medicine market size and projected growth rates for the period of 2023 to 2030. These forecasts will be meticulously segmented by geographical regions within the U.S. and by key market segments to provide actionable insights.

Regional Insight

North America: Dominates the global nuclear medicine market with significant investments in healthcare infrastructure, advanced technologies, and a high prevalence of chronic diseases.
Europe: A sizable market with well-established healthcare systems and a growing focus on precision medicine, driving the adoption of nuclear medicine for disease management.
Asia Pacific: Emerging as a rapidly growing market due to increasing healthcare awareness, rising disposable income, and expanding healthcare infrastructure.
Latin America: Has considerable growth potential due to improving healthcare systems and increasing demand for advanced medical technologies, including nuclear medicine.
Middle East and Africa: Presents growth opportunities with ongoing healthcare reforms and infrastructure developments, though penetration of nuclear medicine varies across countries.

U.S. Nuclear Medicine Market Market Share by Region - Global Geographic Distribution — U.S. Nuclear Medicine Market Regional Market Share

Pricing Analysis

Price comparison of radiopharmaceuticals across different regions
Pricing strategies adopted by leading players
Impact of reimbursement policies on pricing

Import And Export Analysis

Analysis of major import and export trends
Key import and export destinations
Trade regulations and tariffs

Segmentation

Market segmentation by application, end-user, and technology
Market size and growth potential for each segment

Patent/Trademark Analysis

Patent and trademark landscape in the nuclear medicine industry
Key patents and their impact on market dynamics
Analysis of intellectual property protection strategies

U.S. Nuclear Medicine Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 21.2% from 2020-2034
Segmentation	By Type Diagnostic Radiopharmaceuticals {PET Radiopharmaceuticals [FDG-PET/18F 68Ga 68Cu 11C Others] SPECT Radiopharmaceuticals [Technetium-99m Iodine-123 Xenon-133 Thallium-201 Others]} Therapeutic Radiopharmaceuticals By Application Neurology Cardiology Oncology Others By End-user Hospitals & Clinics Diagnostic Centers Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Growing Prevalence of Chronic Diseases to Augment Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Lack of Reimbursement for Diagnostic Radiopharmaceuticals May Hamper Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Technological Advancements in Nuclear Imaging Modalities is a Key Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Nuclear Medicine Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
  - 5.1.1. Diagnostic Radiopharmaceuticals {PET Radiopharmaceuticals [FDG-PET/18F
  - 5.1.2. 68Ga
  - 5.1.3. 68Cu
  - 5.1.4. 11C
  - 5.1.5. Others]
  - 5.1.6. SPECT Radiopharmaceuticals [Technetium-99m
  - 5.1.7. Iodine-123
  - 5.1.8. Xenon-133
  - 5.1.9. Thallium-201
  - 5.1.10. Others]}
  - 5.1.11. Therapeutic Radiopharmaceuticals
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Neurology
  - 5.2.2. Cardiology
  - 5.2.3. Oncology
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by End-user
  - 5.3.1. Hospitals & Clinics
  - 5.3.2. Diagnostic Centers
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Lantheus (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Cardinal Health (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Bracco (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 GE HealthCare (General Electric Company) (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 CURIUM (France)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Bayer AG (Germany)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 RLS Inc. (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Advanced Accelerator Applications (Novartis AG) (France)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Nordion (Canada) Inc. (Canada)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Jubilant Pharma Limited (U.S.)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Nuclear Medicine Market Revenue Breakdown (USD Billion, %) by Product 2025 & 2033
Figure 2: U.S. Nuclear Medicine Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 2: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Type 2020 & 2033
Table 3: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 4: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Application 2020 & 2033
Table 5: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 6: U.S. Nuclear Medicine Market Volume K Tons Forecast, by End-user 2020 & 2033
Table 7: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 8: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Region 2020 & 2033
Table 9: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 10: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Type 2020 & 2033
Table 11: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 12: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Application 2020 & 2033
Table 13: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 14: U.S. Nuclear Medicine Market Volume K Tons Forecast, by End-user 2020 & 2033
Table 15: U.S. Nuclear Medicine Market Revenue USD Billion Forecast, by Country 2020 & 2033
Table 16: U.S. Nuclear Medicine Market Volume K Tons Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Nuclear Medicine Market?

The projected CAGR is approximately 21.2%.

2. Which companies are prominent players in the U.S. Nuclear Medicine Market?

Key companies in the market include Lantheus (U.S.), Cardinal Health (U.S.), Bracco (U.S.), GE HealthCare (General Electric Company) (U.S.), CURIUM (France), Bayer AG (Germany), RLS, Inc. (U.S.), Advanced Accelerator Applications (Novartis AG) (France), Nordion (Canada) Inc. (Canada), Jubilant Pharma Limited (U.S.).

3. What are the main segments of the U.S. Nuclear Medicine Market?

The market segments include Type, Application, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD 3.58 USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Prevalence of Chronic Diseases to Augment Market Growth.

6. What are the notable trends driving market growth?

Technological Advancements in Nuclear Imaging Modalities is a Key Trend.

7. Are there any restraints impacting market growth?

Lack of Reimbursement for Diagnostic Radiopharmaceuticals May Hamper Market Growth.

8. Can you provide examples of recent developments in the market?

June 2023 – SpectronRx and RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the U.S., announced an agreement to significantly enhance the supply and availability of diagnostic and therapeutic radiopharmaceuticals.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion and volume, measured in K Tons.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Nuclear Medicine Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Nuclear Medicine Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Nuclear Medicine Market?

To stay informed about further developments, trends, and reports in the U.S. Nuclear Medicine Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Nuclear Medicine/ Radiopharmaceuticals Market Soars to USD billion , witnessing a CAGR of 19.5 during the forecast period 2025-2033

Nuclear Medicines Radioisotopes Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Nuclear Medicine Software Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Nuclear Medicine Solutions Analysis Report 2025: Market to Grow by a CAGR of XX to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Nuclear Medicine & Radiopharmaceuticals 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report